Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Mayo Clinic
NYU Langone Health
Maastricht University Medical Center
Cancer Trials Ireland
Case Comprehensive Cancer Center
M.D. Anderson Cancer Center
Institut Cancerologie de l'Ouest
The Christie NHS Foundation Trust
University of Washington
Virginia Commonwealth University
University of Kentucky
Stanford University
National Cancer Institute (NCI)
Eli Lilly and Company